Effects of malarial infection on host microsomal drug-metabolizing enzymes.
D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D000840:Anisoles / Q000378:metabolism; D001772:Blood Cell Count; D003580:Cytochromes / Q000032:analysis; D004721:Endoplasmic Reticulum / Q000503:physiopathology; D004790:Enzyme Induction; D006591:Hexobarbital / Q000378:metabolism / Q000494:pharmacology; D008288:Malaria / Q000201:enzymology* / Q000503:physiopathology; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology*; D009019:Morphinans / Q000378:metabolism; D009596:Nitrophenols / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D010659:Phenylhydrazines / Q000494:pharmacology; D010961:Plasmodium; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012156:Reticulocytes / Q000254:growth & development; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000814:Aniline Compounds; D000840:Anisoles; D003580:Cytochromes; D009019:Morphinans; D009596:Nitrophenols; D010659:Phenylhydrazines; D011506:Proteins; D006591:Hexobarbital; D010634:Phenobarbital